Can Therapes Keep Up With Coit 19 Variants?

Can therapes keep up with coit 19 variants o these agents clinically effective in curing or preventing progression to severe disease? Unfortunately, lot of the times we don't have clinical data. If trials sequence these viruses and at least look for certain easily measurable protectors, i think we be able to use that information when a new variant comes. I think so far we are concentrating on the spike protein,. But hopefully theyare mose steadies on other targets. We're talking about arne polymarass proteases, and hopefully they will do it in the steady itself.